Skip to main content
    6

    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.90
    +0.02 (+2.12%)

    Market Cap: $3.10M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    25%(3/12)
    Avg Surprise
    -147.77%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.85
    Range$-0.85 - $-0.85
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-1.96+56.6%
    60d ago$-1.96+56.6%
    30d ago$-0.79-7.6%
    7d ago$-0.79-7.6%
    Current$-0.85
    Revenue Consensus
    $270000
    Range$270000 - $270000
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.72
    Range$-0.72 - $-0.72
    1 analysts
    Revenue Consensus
    $110000
    Range$110000 - $110000
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    -$-0.72---
    Sep 26EST
    -$-0.85---
    Jun 26
    Reported Aug 14
    $-0.90$-0.74-21.62%Miss+79.2%
    Mar 26
    Reported May 15
    $-1.21$-0.99-22.65%Miss+22.2%
    Dec 25
    Reported Mar 26
    $-8.17$-2.00-308.50%Miss-278.2%
    Sep 25
    Reported Nov 13
    $-2.53$-1.84-37.50%Miss+85.4%
    Jun 25
    Reported Aug 13
    $-4.33$-4.96+12.70%Beat+94.9%
    Mar 25
    Reported May 15
    $-1.56$-1.31-19.08%Miss+95.1%
    Dec 24
    Reported Mar 27
    $-2.16$-0.18-1100.00%Miss-526.1%
    Sep 24
    Reported Nov 14
    $-17.35$-17.40+0.29%Beat-109.4%
    Jun 24
    Reported Aug 14
    $-84.60$-33.60-151.79%Miss-7590.9%
    Mar 24
    Reported Apr 1
    $-31.54$-52.80+40.27%Beat-
    Dec 23
    Reported Feb 28
    $-0.34$-0.14-146.43%Miss-
    Sep 23
    Reported Nov 20
    $184.80$228.00-18.95%Miss-
    Jun 23
    Reported Aug 25
    $-1.10$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.07EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-1092.00%
    ROE-332.90%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage-1068.52x
    Current Ratio2.32xQuick Ratio1.78x
    Trading Statistics
    Beta2.40Avg Volume217.66K
    52-Week High$6.2452-Week Low$0.84

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.06
    SMA 20$1.11
    SMA 50$1.07
    SMA 200$1.84
    EMA 10$1.00
    EMA 20$1.05
    EMA 50$1.13
    EMA 200$2.23

    MACD

    Line: -0.05Signal: -0.01Hist: -0.04

    ADX

    ADX: 24.9+DI: 19.3-DI: 26.5

    Aroon & PSAR

    Aroon Up68.0
    Aroon Down100.0
    PSAR$1.49

    Bollinger Bands

    Upper Band$1.45
    Lower Band$0.76
    %B Position6203%(Upper)
    Band Width0.20

    RSI (14-Day)

    Neutral
    38.8

    Momentum Oscillators

    Stoch %K3.9
    Stoch %D3.8
    Williams %R-92.3
    ROC (10d)-28.1%
    Momentum-0.35
    CCI (20d)-106.2
    MFI (14d)40.6

    Volatility Measures

    ATR (14d)$0.13(14.5%)
    StdDev (20d)0.17
    Hist Vol123.6%(High)

    Volume Flow

    VWAP$0.88
    OBV197.9M
    AD Line2.4B
    CMF (20d)0.218

    Volume Metrics

    Avg Vol (20d)224.1K
    Vol Ratio0.2x(Low)
    VWMA (20d)$1.17

    Pivot Points

    R3$0.99
    R2$0.96
    R1$0.92
    Pivot Point$0.90
    S1$0.86
    S2$0.84
    S3$0.79

    Advanced Oscillators

    TSI-10.49
    Ultimate Osc45.0
    KST64.80

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$207,898$162,092$409,110$528,562$307,871$256,283$302,588$148,111$124,972$105,674$118,273$51,188
    Cost of Revenue$151,100$85,715$120,682$537,690$50,051$73,272$118,077$111,687$89,564$65,437$146,257$71,196
    Gross Profit$56,798$76,377$586,327$-100,088$50,881$90,280$197,329$23,606$35,408$40,237$-20,576$-20,008
    Operating Expenses$2.33M$2.17M$2.11M$2.32M$1.86M$2.09M$807,127$2.16M$4.22M$2.82M$1.72M$1.65M
    R&D$598,653$281,464$638,873$809,777$231,912$370,813$613,955$940,063$3.10M$337,182$100,201$263,703
    SG&A$1.73M$1.89M$1.47M$1.51M$1.63M$1.72M$1.61M$1.22M$1.13M$1.08M$1.69M$1.31M
    Operating Income$-2,271,102$-2,094,961$-1,917,351$-2,325,525$-1,606,328$-1,910,938$-2,065,291$-2,118,692$-4,188,750$-1,342,448$-1,894,161$-1,521,762
    Interest Income$5,516$4,806$0$8,739$0$0$0$0$14,962$1.77M$0$5.70M
    Interest Expense$1,403$1,389$3,086$1,708$1,221$1,790$1,422$1,467$3,621$1,402$5,446$431,699
    Income Before Tax$-2,265,586$-2,090,155$-1,440,871$-2,316,786$-1,734,930$-1,877,301$-2,049,675$-2,160,248$-4,173,788$428,048$-2,046,156$4.17M
    Income Tax Expense$0$0$-1,813$250$0$0$-751$250$438$63$61$63
    Net Income$-2,265,586$-2,090,155$-1,439,058$-2,317,036$-1,734,930$-1,877,301$-2,479,394$-2,160,498$-4,174,226$858,455$-6,229,415$8.36M
    EBITDA$-2,181,945$-2,018,323$-1,370,100$-2,248,130$-1,669,914$-1,814,596$-1,988,188$-1,490,394$-1,406,492$576,949$-6,669,610$4.79M
    EBIT$-2,264,183$-2,088,766$-1,437,785$-2,315,078$-1,733,709$-1,875,511$-2,048,253$-2,158,781$-4,170,167$429,450$-6,997,524$4.58M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SXTP

    News

    SXTP Valuation and Fair Value

    P/E
    -0.1x
    P/B
    -0.3x
    See GNG's fair value

    SXTP Profitability: Margins, ROIC and FCF

    Gross margin
    47.4%
    Operating margin
    -1092.0%
    Net margin
    0.0%
    ROE
    -332.9%
    FCF margin
    -680.2%

    SXTP Bull Case vs Bear Case

    Bear case

    • SXTP beat EPS estimates in 25.0% of its last 8 reported quarters.
    • SXTP's quarterly revenue changed -32.5% year over year.

    SXTP Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -187.0%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.85
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About SXTP

    Does SXTP pay dividends?

    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) does not currently pay a regular dividend.

    What is SXTP's market cap?

    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) has a market capitalization of $3.10M with a current stock price of $0.90.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.